News Detail

This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Benzinga · 09/29 14:37

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Stifel analyst Thomas Stephan upgraded STAAR Surgical Co (NASDAQ:STAA) from Hold to Buy and raised the price target from $28 to $31. Staar Surgical closed at $20.87 on Monday. See how other analysts view this stock.
Deutsche Bank analyst Bryan Kraft upgraded Netflix Inc (NASDAQ:NFLX) from Hold to Buy and cut the price target from $100 to $95. Netflix shares closed at $69.23 on Monday. See how other analysts view this stock.
Mizuho analyst David Bellinger upgraded Stitch Fix (NASDAQ:SFIX) from Underperform to Neutral and slashed the price target from $3 to $2.5. Stitch Fix closed at $2.47 on Monday. See how other analysts view this stock.
Craig-Hallum analyst Albert Lowe upgraded Rezolute, Inc. (NASDAQ:RZLT) from Hold to Buy and raised the price target from $4 to $7. Rezolute shares closed at $4.18 on Monday. See how other analysts view this stock.
JP Morgan analyst John Ivankoe upgraded Bloomin’ Brands, Inc. (NASDAQ:BLMN) from Underweight to Neutral and raised the price target from $6 to $13. Bloomin Brands closed at $7.91 on Monday. See how other analysts view this stock.

Considering buying STAA stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.